标题
Second-generation prophylactic HPV vaccines: successes and challenges
作者
关键词
-
出版物
Expert Review of Vaccines
Volume 13, Issue 2, Pages 247-255
出版商
Informa UK Limited
发表日期
2013-12-18
DOI
10.1586/14760584.2014.865523
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Development of human papillomavirus chimaeric L1/L2 candidate vaccines
- (2013) Marieta McGrath et al. ARCHIVES OF VIROLOGY
- Human papillomavirus genotypes distribution in 175 invasive cervical cancer cases from Brazil
- (2013) Cristina Mendes de Oliveira et al. BMC CANCER
- Influence of Oxidation and Multimerization on the Immunogenicity of a Thioredoxin-L2 Prophylactic Papillomavirus Vaccine
- (2013) Hanna Seitz et al. Clinical and Vaccine Immunology
- Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010
- (2013) Lauri E. Markowitz et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
- (2013) Christina Schellenbacher et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Optimization of Multimeric Human Papillomavirus L2 Vaccines
- (2013) Subhashini Jagu et al. PLoS One
- A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix® and Gardasil® Human Papillomavirus Vaccines in 12-15 Year Old Girls
- (2013) Eve Draper et al. PLoS One
- A universal virus-like particle-based vaccine for human papillomavirus: Longevity of protection and role of endogenous and exogenous adjuvants
- (2013) Ebenezer Tumban et al. VACCINE
- A Human Papillomavirus (HPV)In VitroNeutralization Assay That Recapitulates theIn VitroProcess of Infection Provides a Sensitive Measure of HPV L2 Infection-Inhibiting Antibodies
- (2012) Patricia M. Day et al. Clinical and Vaccine Immunology
- Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
- (2012) Peng Guan et al. INTERNATIONAL JOURNAL OF CANCER
- Human Papillomavirus Type Distribution in Invasive Cervical Cancer and High-Grade Cervical Intraepithelial Neoplasia Across 5 Countries in Asia
- (2012) Swee Chong Quek et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Transient expression of Human papillomavirus type 16 L2 epitope fused to N- and C-terminus of coat protein of Potato virus X in plants
- (2012) Noemi Cerovska et al. JOURNAL OF BIOSCIENCES
- Fall in Human Papillomavirus Prevalence Following a National Vaccination Program
- (2012) S. N. Tabrizi et al. JOURNAL OF INFECTIOUS DISEASES
- A Transmembrane Domain and GxxxG Motifs within L2 Are Essential for Papillomavirus Infection
- (2012) M. P. Bronnimann et al. JOURNAL OF VIROLOGY
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
- (2012) Catherine de Martel et al. LANCET ONCOLOGY
- Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate
- (2012) Karen Nieto et al. PLoS One
- Potential Benefits of Second-Generation Human Papillomavirus Vaccines
- (2012) Sorapop Kiatpongsan et al. PLoS One
- VLPs Displaying a Single L2 Epitope Induce Broadly Cross-Neutralizing Antibodies against Human Papillomavirus
- (2012) Ebenezer Tumban et al. PLoS One
- Updating the Natural History of Human Papillomavirus and Anogenital Cancers
- (2012) Anna-Barbara Moscicki et al. VACCINE
- Oral administration of HPV-16 L2 displayed on Lactobacillus casei induces systematic and mucosal cross-neutralizing effects in Balb/c mice
- (2012) Sun-Woo Yoon et al. VACCINE
- A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
- (2012) John T. Schiller et al. VACCINE
- The Biology and Life-Cycle of Human Papillomaviruses
- (2012) John Doorbar et al. VACCINE
- Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine
- (2012) Cecilia M. Roteli-Martins et al. Human Vaccines & Immunotherapeutics
- Prevalence and risk factors of HPV infection among women from various provinces of the world
- (2011) Krishnakumar Vinodhini et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18–45 years
- (2011) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
- (2011) Aimée R. Kreimer et al. JNCI-Journal of the National Cancer Institute
- A Murine Genital-Challenge Model Is a Sensitive Measure of Protective Antibodies against Human Papillomavirus Infection
- (2011) S. Longet et al. JOURNAL OF VIROLOGY
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- Cross-Neutralization Potential of Native Human Papillomavirus N-Terminal L2 Epitopes
- (2011) Michael J. Conway et al. PLoS One
- A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2
- (2011) Ebenezer Tumban et al. PLoS One
- Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies
- (2011) Joseph E. Tota et al. PREVENTIVE MEDICINE
- Human Papillomavirus L2 Facilitates Viral Escape from Late Endosomes via Sorting Nexin 17
- (2011) Martina Bergant Marušič et al. TRAFFIC
- A multimeric L2 vaccine for prevention of animal papillomavirus infections
- (2011) Subhashini Jagu et al. VIROLOGY
- In Vivo Mechanisms of Vaccine-Induced Protection against HPV Infection
- (2010) Patricia M. Day et al. Cell Host & Microbe
- Pathology and epidemiology of HPV infection in females
- (2010) Margaret Stanley GYNECOLOGIC ONCOLOGY
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings
- (2010) Laia Bruni et al. JOURNAL OF INFECTIOUS DISEASES
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection
- (2010) Subhashini Jagu et al. VACCINE
- Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7
- (2010) Jerri do Carmo Caldeira et al. VACCINE
- Impact of HPV in Oropharyngeal Cancer
- (2010) Linda Marklund et al. Journal of Oncology
- The role of furin in papillomavirus infection
- (2009) Patricia M Day et al. Future Microbiology
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
- (2009) Subhashini Jagu et al. JNCI-Journal of the National Cancer Institute
- Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines
- (2009) C. Schellenbacher et al. JOURNAL OF VIROLOGY
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Two Highly Conserved Cysteine Residues in HPV16 L2 Form an Intramolecular Disulfide Bond and Are Critical for Infectivity in Human Keratinocytes
- (2009) Samuel K. Campos et al. PLoS One
- Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20–38) peptide displayed on bacterial thioredoxin
- (2009) Ivonne Rubio et al. VACCINE
- Nuclear location of minor capsid protein L2 is required for expression of a reporter plasmid packaged in HPV51 pseudovirions
- (2009) Kazunari Kondo et al. VIROLOGY
- Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes
- (2008) Kazunari Kondo et al. JOURNAL OF MEDICAL VIROLOGY
- A Direct Comparison of Human Papillomavirus Type 16 L1 Particles Reveals a Lower Immunogenicity of Capsomeres than Viruslike Particles with Respect to the Induced Antibody Response
- (2008) N. Thones et al. JOURNAL OF VIROLOGY
- Arrangement of L2 within the Papillomavirus Capsid
- (2008) C. B. Buck et al. JOURNAL OF VIROLOGY
- Mechanisms of Human Papillomavirus Type 16 Neutralization by L2 Cross-Neutralizing and L1 Type-Specific Antibodies
- (2008) P. M. Day et al. JOURNAL OF VIROLOGY
- Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2
- (2008) H. H. Alphs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
- (2008) F. Xavier Bosch et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search